Psychiatry Update Spring 2022

CHICAGO MARRIOTT DOWNTOWN

CHICAGO, ILLINOIS

June 16, 2022 – June 18, 2022

swoosh
swoosh

AGENDA

All sessions listed in Central time. Agenda subject to change.

ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

Callout Info for program

PART I

PART II

SESSION I: LEARNING OBJECTIVES

Upon completion of this activity, participants will:

  • Have increased knowledge regarding best practices in forming effective and engaging relationships with patients with schizophrenia

  • Have increased knowledge regarding the implications of two common comorbidities, depression and anxiety, with respect to clinical management and treatment decisions for patients with schizophrenia

  • Have increased knowledge regarding the prevalence and risk factors for tardive dyskinesia among patients on antipsychotic medication
  •  
  • Have greater competence related to implementing an evidence-based approach to controlling tardive dyskinesia symptoms in patients on antipsychotic medications

  • Have increased knowledge regarding recent clinical trial data on emerging and novel treatments for schizophrenia
  •  
  • Have greater competence related to assessing patients for treatment-resistant schizophrenia
  •  
  • Have greater competence related to evidence-based clinical management of patients with treatment-resistant schizophrenia

SESSION CHAIR


 

SESSION II: LEARNING OBJECTIVES

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the available data on the impact of the COVID-19 pandemic on psychiatric illnesses
  •  
  • Have increased knowledge regarding the best practices in utilizing telemedicine in psychiatric practice
  •  
  • Have increased knowledge regarding the prevalence and risks for mental health disorders and suicidality among HCPs
  •  
  • Have increased knowledge regarding the roles and responsibilities of nurse practitioners and physician assistants in psychiatric care
  •  
  • Have greater confidence in their ability to incorporate interprofessional strategies into psychiatric care

SESSION CHAIR


 

*pre-recorded

SESSION III: LEARNING OBJECTIVES

Upon completion of this activity, participants will:

  • Have greater competence related to implementing measurement-based care in major depressive disorder (MDD) management
  •  
  • Have increased knowledge regarding the strategies to overcome barriers to optimal management of patients with treatment resistant depression (TRD)
  •  
  • Have increased knowledge regarding the clinical data on novel and emerging treatments for MDD
  •  
  • Have greater confidence in their ability to incorporate interprofessional strategies into MDD care
  •  

SESSION CHAIR


 

SESSION IV: LEARNING OBJECTIVES

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the emerging and novel interventions for treatment of attention deficit hyperactivity disorder (ADHD)
  •  
  • Have greater competence related to managing ADHD in patients with common psychiatric comorbidities
  •  
  • Have greater competence related to supporting and facilitating successful transition of mental healthcare for patients with ADHD as they develop into adults
  •  
  • Have greater confidence in their ability to incorporate interprofessional strategies into ADHD care

SESSION CHAIR


 

SESSION V: LEARNING OBJECTIVES

Upon completion of this activity, participants will:

  • Have increased knowledge regarding recent clinical trial data on emerging and novel therapeutics indicated for bipolar disorders
  •  
  • Have greater competence in accurately identifying depressive episodes related to mood disorders across the spectrum
  •  
  • Have greater confidence in their ability to incorporate interprofessional strategies into bipolar spectrum care

SESSION CHAIR


 

SESSION VI: LEARNING OBJECTIVES

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the evidence-based strategies for improving mental health outcomes for patients from communities of color
  •  
  • Have increased knowledge regarding the unique mental health challenges in the LGBTQ community
  •  
  • Have greater confidence in their ability to incorporate interprofessional strategies to reduce barriers to optimal mental health care to improve equity

SESSION CHAIR


 

SESSION VII: LEARNING OBJECTIVES

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the potential role of evidence-based digital tools in the diagnosis and treatment of psychiatric disorders
  •  
  • Have increased knowledge regarding the available clinical data on pharmacogenomic considerations for clinical management of psychiatric conditions
  •  
  • Have increased knowledge regarding the recent clinical data on the use of psilocybin assisted therapy in specific psychiatric disorders

SESSION CHAIR